ULTRA™ Medical-Grade 1927 nm Fractional Laser Platform

Executive Summary

ULTRA™ is a medical-grade, non-ablative fractional 1927 nm Thulium laser platform engineered for dermatology and aesthetic practices that require predictable clinical outcomes, high patient throughput, and minimal operational complexity. Designed for clinics prioritizing safety, efficiency, and sustainable profitability, ULTRA™ delivers controlled superficial resurfacing, pigment correction, and global skin revitalization with minimal downtime and broad skin-type compatibility.

ULTRA™ is optimized for medical aesthetics, dermatology, and skin-focused practices seeking a scalable solution for treating dyschromia, sun damage, uneven texture, and early signs of aging across all Fitzpatrick skin types.

Investment & Pricing Overview

The ULTRA™ platform is positioned in the mid-to-premium segment of the non-ablative resurfacing market.

Typical system pricing ranges from $85,000 to $110,000 USD, depending on configuration, region, service agreements, and promotional programs. Financing options are commonly available through medical equipment lenders, with estimated monthly payments starting around $1,400–$1,900 per month over a 60-month term (subject to approval).

Due to fast treatment times, low consumable costs, and high patient demand, clinics typically reach break-even within 3 to 6 months under moderate utilization. Expected return on investment generally falls within 12 to 18 months, with accelerated ROI for practices offering treatment packages, memberships, and combination protocols.

Technical Architecture & System Specifications

ULTRA™ operates at a 1927 nm wavelength, which is selectively absorbed by water in the superficial epidermis. This wavelength allows precise targeting of epidermal structures responsible for pigmentation and texture irregularities while minimizing thermal diffusion into deeper tissues.

The system delivers non-ablative fractional energy, creating uniform microscopic thermal zones that stimulate rapid epidermal turnover and superficial collagen remodeling without vaporizing tissue.

ULTRA™ is capable of delivering high peak power (up to approximately 20 watts) to ensure consistent energy delivery even during fast, high-coverage treatments. Fractional microbeam size is optimized for broad coverage while maintaining controlled thermal injury, allowing efficient resurfacing with minimal downtime.

Energy delivery is managed through Cynosure’s IntelliTrak™ roller system, which uses magnetically tracked rollers to ensure consistent spacing and coverage across the treatment area. This prevents overlapping pulses and uneven treatment density. The platform also incorporates Controlled Chaos Technology™, which intelligently distributes energy in a non-linear pattern to reduce bulk heating, improve patient comfort, and maintain uniform results.

The system features a touchscreen user interface with preset treatment protocols and customizable parameters, enabling fast onboarding and consistent protocol execution across providers. Average training time is minimal, allowing clinics to delegate treatments efficiently to trained clinical staff.

Mechanism of Action

ULTRA™ creates thousands of controlled microthermal zones within the epidermis using fractional non-ablative energy. These microthermal injuries trigger the skin’s natural wound-healing cascade, accelerating keratinocyte turnover, improving pigment dispersion, and stimulating superficial collagen remodeling.

Because surrounding tissue remains intact, healing is rapid and predictable. The microchannels created during treatment temporarily enhance skin permeability, allowing increased absorption of topical agents such as tranexamic acid, antioxidants, or growth-factor serums applied immediately post-procedure.

Clinical Indications

ULTRA™ is indicated for superficial skin resurfacing and texture refinement, treatment of benign pigmented lesions including sun spots, freckles, and age spots, and correction of global dyschromia. It is widely used to address photodamage such as actinic keratoses, sun-induced roughness, and uneven tone.

Additional applications include pre-juvenation in younger patients, maintenance therapy for aging skin, enhancement of topical treatment efficacy, and combination protocols with microneedling, radiofrequency, injectable treatments, or deeper resurfacing technologies.

ULTRA™ is suitable for treatment of the face, neck, chest, and other superficial areas and can be safely used year-round on Fitzpatrick skin types I through VI when proper protocols are followed.

Skin Type Compatibility

The non-ablative fractional design of ULTRA™ allows safe and effective treatment across all Fitzpatrick skin types. Adjustable energy parameters and controlled thermal delivery make it particularly valuable for patients with medium to darker skin tones who may be at higher risk of post-inflammatory hyperpigmentation with more aggressive resurfacing systems.

Safety Architecture & Patient Comfort

ULTRA™ is designed to minimize epidermal disruption while delivering clinically meaningful results. Patients typically experience mild to moderate erythema immediately following treatment and a temporary rough or sandpaper-like texture that resolves within several days. Social downtime is minimal, making ULTRA™ attractive to patients seeking visible improvement without extended recovery.

Energy levels can be adjusted to accommodate patient sensitivity, skin condition, and treatment goals. Topical anesthetics may be used for higher-intensity protocols, though many treatments are well tolerated without anesthesia.

Uniform energy distribution and controlled thermal exposure reduce the risk of hot spots, overtreatment, and inconsistent outcomes.

Revenue Model & Practice Economics

ULTRA™ treatments are fast and efficient, with most facial procedures completed in 10 to 20 minutes. This enables high daily treatment volumes and strong revenue generation per treatment room.

Typical U.S. market pricing places single-session facial resurfacing or pigment correction treatments between $400 and $800 per session, while full face and neck or chest treatments commonly range from $900 to $1,600 per session. Most patients undergo a series of 3 to 6 sessions, making prepaid packages and treatment plans a major driver of recurring revenue.

Because ULTRA™ requires minimal consumables and can be delegated to trained staff, per-treatment operating costs remain low, supporting high margins and predictable profitability.

Competitive Positioning

ULTRA™ occupies a strategic position between light aesthetic treatments and aggressive ablative resurfacing lasers. Compared to traditional resurfacing systems, ULTRA™ offers significantly reduced downtime, broader skin-type compatibility, and higher patient compliance.

Its combination of safety, speed, and versatility makes it ideal for practices focused on scalable skin health services rather than single-event, high-downtime procedures.

Regulatory & Compliance

ULTRA™ is manufactured under established medical device quality systems and is intended for dermatological procedures involving soft tissue coagulation, superficial skin resurfacing, and benign lesion treatment. Use should comply with regional regulatory approvals and clinical guidelines and be performed by trained medical professionals.

Training, Support & Longevity

ULTRA™ includes comprehensive onboarding, clinical education, and ongoing support resources. Clinics receive access to training programs, protocol guidance, educational webinars, and professional user communities. The system is engineered for long-term clinical use with routine calibration and software updates to ensure consistent performance.

Frequently Asked Questions

ULTRA™ is not a hair-removal device and does not treat white or gray hair. Most patients notice visible improvement after one to three sessions, with optimal results achieved through a customized treatment series. ULTRA™ integrates seamlessly with other aesthetic modalities, allowing providers to build layered combination protocols for enhanced outcomes.